New York City, NY -- (SBWIRE) -- 01/23/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Cleveland BioLabs, Inc. (NASDAQ:CBLI), Zhone Technologies Inc (NASDAQ:ZHNE), Hercules Offshore, Inc. (NASDAQ:HERO), DARA Biosciences Inc (NASDAQ:DARA)
Cleveland BioLabs, Inc. (NASDAQ:CBLI) declined -34.50% recently, while trading on 2.48 million shares, at the price of $0.740. The stock changed hands in a range of $0.63 to $0.84 up till now, bringing its market capitalization at about $33.23 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.63 and was moved to the maximum level of $2.28. Cleveland BioLabs, Inc. is a clinical-stage biotechnology company with a focus on oncology drug development. The Company’s lead drug candidate CBLB502 is developed for dual indications under the United States Food & Drug Administration's (FDA's) Animal Efficacy Rule, commonly referred to as the Animal Rule, as a radiation countermeasure, and under the FDA's traditional drug approval pathway as an anti-cancer agent and an oncology supportive care therapy.
Has CBLI Found The Bottom and Ready To Move Up? Find Out Here
Zhone Technologies Inc (NASDAQ:ZHNE) declined -22.71% recently, in the current trading session, at $4.80 with a total volume of 1.30 million shares. The stock, on average, trades on a volume of 836,489 shares. It floated in a range of $4.70 to $5.14 during the recent trading session, with a beta value of 1.96. Its market capitalization now moved to about $149.81 million. In the past 52 weeks, the share price has not declined below $0.56 or above $6.62. Zhone Technologies Inc. (Zhone) designs, develops and manufactures communications networks equipment for telecommunications, wireless and cable operators worldwide. With the Company's products and solutions, network service providers can migrate from traditional circuit-based networks to packet-based networks and from copper-based access lines to fiber-based access lines without abandoning the investments they have made in their existing infrastructures.
Has ZHNE Found The Bottom And Ready To Gain Momentum? Find Out Here
Hercules Offshore, Inc. (NASDAQ:HERO) recently recorded a fall of -13.39% and was moving within a range of $4.75-$5.48, its current trading price is $4.99. The stock is moving up till now with a total volume of 3.42 million shares, versus an average volume of 2.65 million shares. The share price hit its 52-week low of $4.75 and $7.96 was the best price. Hercules Offshore, Inc. (Hercules Offshore) provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry globally. It provides these services to national oil and gas companies, integrated energy companies and independent oil and natural gas operators.
Why Should Investors Buy HERO After the Recent Fall? Just Go Here and Find Out
DARA Biosciences Inc (NASDAQ:DARA) declined -6.90% in its current trading activity, bringing its market capitalization around $25.09 million. The share price, after opening at $0.82, hit a high of $0.83 and hovered above $0.76, while its recent trading price was $0.810. The total number of shares changed hands during the current session up till now was 1.49 million shares, as compared to average trading volume of 1.78 million shares. DARA BioSciences, Inc. is a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care pharmaceutical products. The Company has the exclusive United States marketing rights to its Soltamox (oral liquid tamoxifen).
Will DARA Get Buyers Even After The Recent Rally? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)